| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8681801 | Clinical Neurology and Neurosurgery | 2018 | 6 Pages |
Abstract
Our study indicated that increased expression of CPEB4 in primary glioblastoma is a novel biomarker for predicting poor outcome of patients and suppression of CPEB4 inhibit tumor cell proliferation, suggesting a potential therapeutic target for glioblastoma.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Hong-xiang Wang, Rong Qin, Jian Mao, Qi-lin Huang, Fan Hong, Feng Li, Zhen-yu Gong, Tao Xu, Yong Yan, Shao-hui Chao, Shi-kun Zhang, Ju-xiang Chen,